Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient

Treatment of relapsed/refractory or elderly unfit acute myeloid leukemia (AML) is still challenging, and hypomethylating agents in combination with venetoclax, an oral selective BCL2 inhibitor, might be successfully used as salvage therapy. However, clinical trials evaluating the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Serio, Bianca, Giudice, Valentina, Morini, Denise, Guariglia, Roberto, Vitolo, Rosa, Manzo, Paola, Langella, Maddalena, Selleri, Carmine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247557/
https://www.ncbi.nlm.nih.gov/pubmed/35949908
http://dx.doi.org/10.1159/000524952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9247557/
https://www.ncbi.nlm.nih.gov/pubmed/35949908
http://dx.doi.org/10.1159/000524952

Ejemplares similares